Cui L, Xia W, Yu C, Dong S, Pei Y (2022) Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis. Arch Osteoporos 17:74

Article  PubMed  PubMed Central  Google Scholar 

Fujiwara S, Miyauchi A, Hamaya E, Nicholls RJ, Weston A, Baidya S, Pinto L, Barron R, Takada J (2018) Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review. Arch Osteoporos 13:34

Article  PubMed  Google Scholar 

Noguchi Y, Kawate H, Nomura M, Takayanagi R (2013) Eldecalcitol for the treatment of osteoporosis. Clin Interv Aging 8:1313–1321

PubMed  PubMed Central  Google Scholar 

Matsumoto T, Ito M, Hayashi Y, Hirota T, Tanigawara Y, Sone T, Fukunaga M, Shiraki M, Nakamura T (2011) A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures–a randomized, active comparator, double-blind study. Bone 49:605–612

Article  CAS  PubMed  Google Scholar 

Xu Z, Fan C, Zhao X, Tao H (2016) Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials. Drug Des Devel Ther 10:509–517

CAS  PubMed  PubMed Central  Google Scholar 

Aihara S, Yamada S, Oka H, Kamimura T, Nakano T, Tsuruya K, Harada A (2019) Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility. Ren Fail 41:88–97

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker MD, Shane E (2022) Hypercalcemia: a review. JAMA 328:1624–1636

Article  CAS  PubMed  Google Scholar 

Saito H, Kakihata H, Nishida Y, Yatomi S, Nihojima S, Kobayashi Y, Tabata H, Nomura M (2017) The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese patients with osteoporosis: interim report. J Bone Miner Metab 35:456–463

Article  CAS  PubMed  Google Scholar 

Takeuchi Y, Saito H, Makishima M, Yokoyama H, Yamaguchi T, Fujii H, Inoue E, Isemura T, Kondo S, (2022) Long-term safety of eldecalcitol in Japanese patients with osteoporosis: a retrospective, large-scale database study. J Bone Miner Metab 275–291

Pharmaceuticals and Medical Devices Agency alert for proper use of drugs. Hypercalcemia induced by eldecalcitol and compliance with laboratory testing. Available: https://www.pmda.go.jp/files/000237333.pdf. Accessed Jan, 2023.

Pharmacoepidemiology & Database Taskforce, Japanese Society for Pharmacoepidemiology. Survey of Japanese databases in Japan available for clinical/pharmacoepidemiology. Available: http://www.jspe.jp/committee/020/0210/. Accessed Jan, 2023.

Ri K, Fukasawa T, Yoshida S, Takeuchi M, Kawakami K (2023) Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case-crossover study. Pharmacotherapy 43:136–144

Article  CAS  PubMed  Google Scholar 

Yoshida S, Takeuchi M, Tanaka-Mizuno S, Mizuno K, Nakashima M, Fukasawa T, Kawakami K (2022) Clinical epidemiology and pharmacoepidemiology studies with real-world databases. Proceedings of the Japan Academy, Series B 98:517–528

Article  Google Scholar 

Hashimoto H, Takeuchi M, Kawakami K (2022) Association between biopsies for anti-neutrophil cytoplasmic antibody-associated vasculitis and prognosis: a retrospective cohort study. Clin Rheumatol 41:541–548

Article  PubMed  Google Scholar 

Usui T, Funagoshi M, Seto K, Ide K, Tanaka S, Kawakami K (2018) Persistence of and switches from teriparatide treatment among women and men with osteoporosis in the real world: a claims database analysis. Arch Osteoporos 13:54

Article  PubMed  Google Scholar 

Lyu H, Yoshida K, Zhao SS, Wei J, Zeng C, Tedeschi SK, Leder BZ, Lei G, Tang P, Solomon DH (2020) Delayed Denosumab injections and fracture risk among patients with osteoporosis. Ann Intern Med 173:516–526

Article  PubMed  Google Scholar 

Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083–3107

Article  PubMed  PubMed Central  Google Scholar 

Mulla ZD, Seo B, Kalamegham R, Nuwayhid BS (2009) Multiple imputation for missing laboratory data: an example from infectious disease epidemiology. Ann Epidemiol 19:908–914

Article  PubMed  Google Scholar 

Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393

Article  PubMed  PubMed Central  Google Scholar 

National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201

Article  Google Scholar 

Jean G, Souberbielle JC, Chazot C (2017) Vitamin D in chronic kidney disease and dialysis patients. Nutrients 9:328

Article  PubMed  PubMed Central  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7:1–59

Article  Google Scholar 

Deng Y-L, Hsu C-S, Hsu C-Y, Chen C-H, Ou S-F, Liu C-F, Yang S-H, Shih C-H, Chen Y-M, Lee H-T (2022) Predictors for self-discontinuation of anti-osteoporosis medication: a hospital-based real-world study. PLoS ONE 17:e0275020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dennis MW (2018) Clinical pharmacology of corticosteroids. Respir Care 63:655

Article  Google Scholar